Skip to Main Content

Author Details

Mandeep Takhar
GenomeDx Biosciences Inc.
2010
40
23
PMIDPaper TitleJournal TitlePublished Year
30367117Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.Prostate Cancer Prostatic Dis2019
32914029Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.JCO Precis Oncol2019
30224344Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.Clin Cancer Res2019
31206668Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.J Pathol2019
31515477Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease.Nat Commun2019
31125117Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.Int J Cancer2019
31107158African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.J Urol2019
28753844Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.Eur Urol Focus2018
30108099Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer.Cancer Epidemiol Biomarkers Prev2018
30563651Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.J Urol2018
28330676Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.Eur Urol2018
28400167Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.Eur Urol2018
29729848Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.EBioMedicine2018
29511883Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.J Cancer Res Clin Oncol2018
29760221Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.Clin Cancer Res2018
29757368The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.Gigascience2018
27801901Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.Prostate Cancer Prostatic Dis2017
28415728Lipid degradation promotes prostate cancer cell survival.Oncotarget2017
28107602Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality.BJU Int2017
28145883Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.Oncotarget2017
28092670Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.Oncogene2017
28916652LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.Cancer Res2017
28562641PGCA: An algorithm to link protein groups created from MS/MS data.PLoS One2017
28591577Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.Cell Rep2017
27105761Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.J Urol2016
29188191Prostate cancer radiomics and the promise of radiogenomics.Transl Cancer Res2016
27842512SABRE: a method for assessing the stability of gene modules in complex tissues and subject populations.BMC Bioinformatics2016
27713863Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report.Urol Case Rep2016
27302169Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.Cancer Res2016
27438142Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.Oncotarget2016
27015368The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.Oncotarget2016
26175416DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.Cancer Cell2015
24919196A TRIP230-retinoblastoma protein complex regulates hypoxia-inducible factor-1α-mediated transcription and cancer cell invasion.PLoS One2014
23592955Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.PLoS Comput Biol2013
22235307Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.PLoS One2012
23216969A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers.BMC Bioinformatics2012
22930592Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge.Proteomics Clin Appl2012
22674792Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.Stem Cells2012
20501940Proteomic signatures in plasma during early acute renal allograft rejection.Mol Cell Proteomics2010
20716622Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity.J Pharmacol Exp Ther2010
  • 1 - 40 of 40

Recommended Authors

Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 9
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 14
Natalie Kurganovs
Australian Prostate Cancer Research Centre Epworth
Career Start Year 2015
Number of shared co-authors 8
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 12
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 8
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 39
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 31
Cindy Q Yao
Ontario Institute for Cancer Research
Career Start Year 2011
Number of shared co-authors 26
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 23
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 30
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 7
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 5
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 3
Adam Foye
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 21
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 21
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 10
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 15
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 2
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 32
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 10
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 10
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 19
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 21
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 8
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 56
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 22
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 15
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 16
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 25

Collaborators

Elai Davicioni
Veracyte Inc.
Co-authored papers 27
Nicholas Erho
GenomeDx Biosciences Inc.
Co-authored papers 24
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 15
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 13
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Co-authored papers 11
Ashley E Ross
Northwestern University
Co-authored papers 11
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 10
Eric A Klein
Cleveland Clinic
Co-authored papers 10
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 6
Colin C Collins
University of British Columbia
Co-authored papers 5
Martin E Gleave
University of British Columbia
Co-authored papers 4
Stephen J Freedland
Cedars-Sinai Medical Center
Co-authored papers 4
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 4
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers 3
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Co-authored papers 3
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Co-authored papers 3
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 3
Lucia L Lam
School of Clinical Medicine, University of Hong Kong, Queen Mary Hospital
Co-authored papers 3
Christoph H Borchers
McGill University
Co-authored papers 3
Varune R Ramnarine
University of British Columbia
Co-authored papers 3
Yuzhuo Wang
University of British Columbia
Co-authored papers 2
Robert H Bell
University of British Columbia
Co-authored papers 2
Amina Zoubeidi
University of British Columbia
Co-authored papers 2
Alexander W Wyatt
University of British Columbia
Co-authored papers 2
Ralph Buttyan
University of British Columbia
Co-authored papers 2
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers 2
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 2
Sonal Brahmbhatt
University of British Columbia
Co-authored papers 2
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 2
Ian G Mills
Queen's University Belfast
Co-authored papers 2
Release 1.2